Anavex Life Sciences Corp (AVXL)

[BAR123]

Keep in mind that the company will not be actively marketing the product. This is for compassionate use mainly for the 32 phase 2 trial participants. I believe that things heat up once we have great data on PDD and Rett. They can then go back to the TGA with double blind placebo data and look for priority review. That should be the strategy. Then take all this great data to the FDA and Europe. Oh and don’t forget the Japan partnership.